Lazard Ltd
Lazard, Inc. operates as a financial advisory and asset management firm in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Financial Advisory and Asset Management. The Financial Advisory segment offers financial advisory services, such as mergers and acquisitions, capital markets, shareholder, sovereign, geopolitical, and other strategic … Read more
Lazard Ltd (LAZ) - Total Liabilities
Latest total liabilities as of December 2025: $3.95 Billion USD
Based on the latest financial reports, Lazard Ltd (LAZ) has total liabilities worth $3.95 Billion USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Lazard Ltd - Total Liabilities Trend (2002–2025)
This chart illustrates how Lazard Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Lazard Ltd Competitors by Total Liabilities
The table below lists competitors of Lazard Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nissan Chemical Corporation
PINK:NNCHF
|
USA | $80.87 Billion |
|
E Ink Holdings
TWO:8069
|
Taiwan | NT$36.74 Billion |
|
Yunnan Chihong Zinc&Germanium Co Ltd
SHG:600497
|
China | CN¥6.69 Billion |
|
Ryan Specialty Group Holdings Inc
NYSE:RYAN
|
USA | $9.31 Billion |
|
Kymera Therapeutics Inc
NASDAQ:KYMR
|
USA | $155.79 Million |
|
Allete Inc
NYSE:ALE
|
USA | $3.81 Billion |
|
TongKun Group Co Ltd
SHG:601233
|
China | CN¥75.55 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down Lazard Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.80 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lazard Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lazard Ltd (2002–2025)
The table below shows the annual total liabilities of Lazard Ltd from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.95 Billion | -1.93% |
| 2024-12-31 | $4.03 Billion | -0.90% |
| 2023-12-31 | $4.07 Billion | -11.49% |
| 2022-12-31 | $4.59 Billion | -16.39% |
| 2021-12-31 | $5.49 Billion | +10.49% |
| 2020-12-31 | $4.97 Billion | -0.21% |
| 2019-12-31 | $4.98 Billion | +23.73% |
| 2018-12-31 | $4.03 Billion | +9.84% |
| 2017-12-31 | $3.67 Billion | +12.38% |
| 2016-12-31 | $3.26 Billion | +4.59% |
| 2015-12-31 | $3.12 Billion | +20.89% |
| 2014-12-31 | $2.58 Billion | +8.37% |
| 2013-12-31 | $2.38 Billion | +1.96% |
| 2012-12-31 | $2.34 Billion | +5.43% |
| 2011-12-31 | $2.22 Billion | -15.66% |
| 2010-12-31 | $2.63 Billion | +0.21% |
| 2009-12-31 | $2.62 Billion | +2.76% |
| 2008-12-31 | $2.55 Billion | -31.39% |
| 2007-12-31 | $3.72 Billion | +9.54% |
| 2006-12-31 | $3.39 Billion | +27.11% |
| 2005-12-31 | $2.67 Billion | -9.18% |
| 2004-12-31 | $2.94 Billion | +8.02% |
| 2003-12-31 | $2.72 Billion | +50.21% |
| 2002-12-31 | $1.81 Billion | -- |